vcfirmsdirectory.com

Venture capital

PsyMed Ventures

Specialist venture fund backing founders in brain and mental health, spanning neurotech, novel therapeutics, digital health and precision neuroscience.

Registered · United States
New investments · 12 months
Fund vehiclesPublic
2
2 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: psymed.ventures · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round PsyMed Ventures joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is PsyMed Ventures right for your round?

Is PsyMed Ventures a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
2
2 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

PSYMED VENTURES LPUS private fund · Active · United States · $14.2M gross assets · filed 26 Feb 2026
PSYMED VENTURES FUND II, LPUS private fund · Active · United States · $10.9M gross assets · filed 26 Feb 2026
Deployed (new cheques)
Next fund expected

Latest investments

Rounds PsyMed Ventures joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round PsyMed Ventures joined

Round sizes, PsyMed Ventures’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

AERSKAANCILIABEXSON BIOMEDICALBLOOM SCIENCEBRIGHT MINDSDELIX THERAPUTICSFREEDOM BIOSCIENCESGILGAMESH PHARMACEUTICALSHUMANS ANONYMOUSIMYOOand 13 more

Portfolio and exits

Every company PsyMed Ventures backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where PsyMed Ventures puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet PsyMed Ventures

Events where PsyMed Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet PsyMed Ventures’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

26 Feb 2026Fund filingForm ADV filed by PSYMED VENTURES MANAGEMENT LLC: 2 private funds, $25.1M in gross assets.SEC Form ADV · public record
17 Jul 2024New deal

Founders also look at

Frequently asked questions

PsyMed Ventures is based in the United States.

2 fund vehicles are on public registers (SEC adviser filings), including PSYMED VENTURES LP and PSYMED VENTURES FUND II, LP.

Sectors: Health tech, Biotech, AI, Life sciences. From the firm’s own website.

Backs frontier technologies and neuroscience-driven founders working to address the mental and brain illness epidemic. Focus areas include AI, neurotech and brain-computer interfaces, precision neuroscience, new modalities such as RNA and genetic medicines, holistic medicine, neurometabolism, and digital therapeutics. From the firm’s own website.

PsyMed Ventures lists 23 portfolio companies on its website, including AERSKA, ANCILIA, BEXSON BIOMEDICAL, BLOOM SCIENCE and BRIGHT MINDS.

Firms whose websites list some of the same companies include GREY HOUSE PARTNERS GP INC., Actions and AlleyCorp.

Know before PsyMed Ventures’s next round is announced.

PRO tracks PsyMed Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

PsyMed VenturesGet PsyMed Ventures’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.